| |
| |
|
| Insider
Information: |
Gustafson Kurt A |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
535,630 |
|
|
Indirect Shares
|
11,840 |
|
|
| Direct
Value |
$2,816,060 |
|
|
|
Indirect Value
|
$12,195 |
|
|
| Total
Shares |
547,470 |
|
|
| Total
Value |
$2,828,255 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
3
|
|
Stock
price went up :
|
1
|
1
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
1.0
|
| Percentage
Gain/Loss : |
 103.1%
|
 -31.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Halozyme Therapeutics Inc |
HALO |
Vice President and CFO |
2013-02-02 |
35,667 |
2011-08-09 |
0 |
Premium* |
|
|
Spectrum Pharmaceuticals Inc |
SPPI |
EVP & Chief Financial ... |
2022-03-16 |
317,259 |
2022-03-16 |
11,840 |
Premium* |
|
|
OmniAb, Inc |
OABI |
Executive VP, Finance ... |
2024-04-08 |
176,697 |
2022-11-01 |
0 |
Premium* |
|
|
Xencor Inc |
XNCR |
Director |
2024-03-06 |
6,007 |
2023-06-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
64 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SPPI |
Spectrum Pharmaceuticals ... |
EVP & Chief Financial Officer |
• – – |
2020-02-19 |
4 |
AS |
$2.77 |
$13,115 |
D/D |
(4,733) |
208,444 |
0 |
% |
|
| SPPI |
Spectrum Pharmaceuticals ... |
EVP & Chief Financial Officer |
• – – |
2020-02-20 |
4 |
AS |
$2.85 |
$9,499 |
D/D |
(3,333) |
205,111 |
0 |
% |
|
| SPPI |
Spectrum Pharmaceuticals ... |
EVP & Chief Financial Officer |
• – – |
2020-03-31 |
4 |
AS |
$2.31 |
$9,989 |
D/D |
(4,326) |
363,965 |
0 |
% |
|
| SPPI |
Spectrum Pharmaceuticals ... |
EVP & Chief Financial Officer |
• – – |
2020-04-01 |
4 |
AS |
$2.23 |
$6,991 |
D/D |
(3,135) |
360,830 |
0 |
% |
|
| SPPI |
Spectrum Pharmaceuticals ... |
EVP & Chief Financial Officer |
• – – |
2020-12-14 |
4 |
AS |
$5.00 |
$128,480 |
D/D |
(25,696) |
335,134 |
0 |
% |
|
| SPPI |
Spectrum Pharmaceuticals ... |
EVP & Chief Financial Officer |
• – – |
2021-01-19 |
4 |
AS |
$3.81 |
$9,832 |
D/D |
(2,582) |
332,552 |
0 |
% |
|
| SPPI |
Spectrum Pharmaceuticals ... |
EVP & Chief Financial Officer |
• – – |
2021-01-20 |
4 |
AS |
$4.31 |
$8,379 |
D/D |
(1,944) |
330,608 |
0 |
% |
|
| SPPI |
Spectrum Pharmaceuticals ... |
EVP & Chief Financial Officer |
• – – |
2021-02-19 |
4 |
AS |
$3.64 |
$16,992 |
D/D |
(4,672) |
441,134 |
0 |
% |
|
| SPPI |
Spectrum Pharmaceuticals ... |
EVP & Chief Financial Officer |
• – – |
2021-02-22 |
4 |
AS |
$3.73 |
$14,920 |
D/D |
(4,000) |
437,134 |
0 |
% |
|
| SPPI |
Spectrum Pharmaceuticals ... |
EVP & Chief Financial Officer |
• – – |
2021-03-15 |
4 |
AS |
$3.63 |
$73,823 |
D/D |
(20,365) |
416,769 |
0 |
% |
|
| SPPI |
Spectrum Pharmaceuticals ... |
EVP & Chief Financial Officer |
• – – |
2021-03-16 |
4 |
AS |
$3.69 |
$60,213 |
D/D |
(16,318) |
400,451 |
0 |
% |
|
| SPPI |
Spectrum Pharmaceuticals ... |
EVP & Chief Financial Officer |
• – – |
2022-02-23 |
4 |
AS |
$0.70 |
$14,211 |
D/D |
(20,215) |
366,188 |
0 |
% |
|
| SPPI |
Spectrum Pharmaceuticals ... |
EVP & Chief Financial Officer |
• – – |
2022-02-24 |
4 |
AS |
$0.64 |
$10,213 |
D/D |
(15,958) |
354,230 |
0 |
% |
|
| SPPI |
Spectrum Pharmaceuticals ... |
EVP & Chief Financial Officer |
• – – |
2022-03-15 |
4 |
AS |
$0.71 |
$14,560 |
D/D |
(20,653) |
333,577 |
0 |
% |
|
| SPPI |
Spectrum Pharmaceuticals ... |
EVP & Chief Financial Officer |
• – – |
2022-03-16 |
4 |
AS |
$0.71 |
$11,521 |
D/D |
(16,318) |
317,259 |
0 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
Vice President and CFO |
• – – |
2011-08-09 |
4 |
B |
$5.88 |
$47,010 |
D/D |
8,000 |
8,000 |
2.74 |
- |
|
| OABI |
OmniAb, Inc |
EVP, Finance and CFO |
• – – |
2022-11-28 |
4 |
B |
$2.81 |
$28,100 |
D/D |
10,000 |
170,062 |
2.74 |
% |
|
| SPPI |
Spectrum Pharmaceuticals ... |
EVP & Chief Financial Officer |
• – – |
2014-06-03 |
4 |
D |
$7.73 |
$77,586 |
D/D |
(10,037) |
106,763 |
0 |
- |
|
| SPPI |
Spectrum Pharmaceuticals ... |
EVP & Chief Financial Officer |
• – – |
2015-02-18 |
4 |
D |
$7.23 |
$20,765 |
D/D |
(2,872) |
131,766 |
0 |
- |
|
| SPPI |
Spectrum Pharmaceuticals ... |
EVP & Chief Financial Officer |
• – – |
2015-06-03 |
4 |
D |
$6.19 |
$62,315 |
D/D |
(10,067) |
121,699 |
0 |
- |
|
| SPPI |
Spectrum Pharmaceuticals ... |
EVP & Chief Financial Officer |
• – – |
2016-02-18 |
4 |
D |
$4.55 |
$12,144 |
D/D |
(2,669) |
119,030 |
0 |
- |
|
| SPPI |
Spectrum Pharmaceuticals ... |
EVP & Chief Financial Officer |
• – – |
2016-03-22 |
4 |
D |
$6.08 |
$18,301 |
D/D |
(3,010) |
146,020 |
0 |
- |
|
| SPPI |
Spectrum Pharmaceuticals ... |
EVP & Chief Financial Officer |
• – – |
2016-03-25 |
4 |
D |
$5.96 |
$9,089 |
D/D |
(1,525) |
144,495 |
0 |
- |
|
| SPPI |
Spectrum Pharmaceuticals ... |
EVP & Chief Financial Officer |
• – – |
2016-06-03 |
4 |
D |
$7.52 |
$75,501 |
D/D |
(10,040) |
144,122 |
0 |
- |
|
| SPPI |
Spectrum Pharmaceuticals ... |
EVP & Chief Financial Officer |
• – – |
2017-02-18 |
4 |
D |
$5.91 |
$14,604 |
D/D |
(2,471) |
139,567 |
0 |
- |
|
64 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
